HHIP and chronic obstructive pulmonary disease: Though further direct evidence in vivo is still needed, our current data from mixed models including primary human normal and COPD-derived ASMC cultures as well as Hhip+/- mice suggested HHIP protected the lung from airway remodeling possibly by repressing ASMC hyperproliferation associated with metabolic reprogramming towards aerobic glycolysis.